Skip to content

WisdomTree WT Remeasurement Of Contingent Consideration

Remeasurement Of Contingent Consideration at other companies

Haemonetics logo
HaemoneticsHAE
-$469.75K+91.8%
LifeStance Health Group logo
LifeStance Health GroupLFST
-$5K
Tetra Tech logo
Tetra TechTTEK
$58K-97.0%
RadNet logo
RadNetRDNT
-$2.76M
Commvault Systems logo
Commvault SystemsCVLT
$0
Rumble, Inc. logo
Rumble, Inc.RUM
$338.59K

Other financials

Income statement

See full
Revenue$159.5M+47.5%
Operating income$59.4M+73.7%
Net income-$23.1M-194%
EPS (diluted)-$0.17-200%

Balance sheet

See full
Cash & equivalents$625.5M+1,658%
Total debt$2.3M-82.3%
Total equity$475.0M+14.3%
Total assets$1.8B+74.4%

Cash flow

See full
Operating cash flow$18.0M+182%
CapEx$28.0K-9.7%
Free cash flow$17.9M+183%

Valuation

See full
Market cap$2.8B+57.2%
Enterprise value$2.18B+11.6%
P/E45.7×+19.9×
P/S5.1×+1.1×

Profitability

See full
Gross margin82.5%
Operating margin36.6%+3.9pp
Net margin11.3%-4.5pp
FCF margin29.2%+1.7pp

Returns & leverage

See full
Return on equity13.8%-2.7pp
Debt / equity0.0×
Current ratio4.6×+0.7×

Where this comes from

Reported directly by WisdomTree in its filing.

Tagged under the XBRL concept wti:RemeasurementOfContingentConsideration.

The official record: WisdomTree’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about WisdomTree's remeasurement of contingent consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is WisdomTree's remeasurement of contingent consideration?
WisdomTree (WT) reported remeasurement of contingent consideration of -$2.56M in Q1 2026.
How has WisdomTree's remeasurement of contingent consideration changed year-over-year?
WisdomTree's remeasurement of contingent consideration decreased by 1343.4% year-over-year, from -$177.5K to -$2.56M.
What does remeasurement of contingent consideration mean?
Reflects adjustments to the fair value of earn-out provisions or performance-based payments owed to sellers of acquired entities. Changes in this value indicate shifts in the expected future performance of acquired assets relative to initial acquisition projections.